Cargando…
Imipramine Influences Body Distribution of Supplemental Zinc Which May Enhance Antidepressant Action
Zinc (Zn) was found to enhance the antidepressant efficacy of imipramine (IMI) in human depression and animal tests/models of depression. However, the underlying mechanism for this effect remains unknown. We measured the effect of intragastric (p.o.) combined administration of IMI (60 mg/kg) and Zn...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7551732/ https://www.ncbi.nlm.nih.gov/pubmed/32825449 http://dx.doi.org/10.3390/nu12092529 |
_version_ | 1783593244460843008 |
---|---|
author | Rafało-Ulińska, Anna Poleszak, Ewa Szopa, Aleksandra Serefko, Anna Rogowska, Magdalena Sowa, Ireneusz Wójciak, Magdalena Muszyńska, Bożena Krakowska, Agata Gdula-Argasińska, Joanna Kała, Katarzyna Jasiewicz, Barbara Opoka, Włodzimierz Szewczyk, Bernadeta Nowak, Gabriel |
author_facet | Rafało-Ulińska, Anna Poleszak, Ewa Szopa, Aleksandra Serefko, Anna Rogowska, Magdalena Sowa, Ireneusz Wójciak, Magdalena Muszyńska, Bożena Krakowska, Agata Gdula-Argasińska, Joanna Kała, Katarzyna Jasiewicz, Barbara Opoka, Włodzimierz Szewczyk, Bernadeta Nowak, Gabriel |
author_sort | Rafało-Ulińska, Anna |
collection | PubMed |
description | Zinc (Zn) was found to enhance the antidepressant efficacy of imipramine (IMI) in human depression and animal tests/models of depression. However, the underlying mechanism for this effect remains unknown. We measured the effect of intragastric (p.o.) combined administration of IMI (60 mg/kg) and Zn (40 mg Zn/kg) in the forced swim test (FST) in mice. The effect of Zn + IMI on serum, brain, and intestinal Zn concentrations; Zn transporter (ZnT, ZIP) protein levels in the intestine and ZnT in the brain; including BDNF (brain-derived neurotrophic factor) and CREB (cAMP response element-binding protein) protein levels in the brain were evaluated. Finally, the effect of IMI on Zn permeability was measured in vitro in colon epithelial Caco-2 cells. The co-administration of IMI and Zn induced antidepressant-like activity in the FST in mice compared to controls and Zn or IMI given alone. This effect correlated with increased BDNF and the ratio of pCREB/CREB protein levels in the prefrontal cortex (PFC) compared to the control group. Zn + IMI co-treatment increased Zn concentrations in the serum and brain compared to the control group. However, in serum, co-administration of IMI and Zn decreased Zn concentration compared to Zn alone treatment. Also, there was a reduction in the Zn-induced enhancement of ZnT1 protein level in the small intestine. Zn + IMI also induced an increase in the ZnT4 protein level in the PFC compared to the control group and normalized the Zn-induced decrease in the ZnT1 protein level in the hippocampus (Hp). The in vitro studies revealed enhanced Zn permeability (observed as the increased transfer of Zn through the intestinal cell membrane) after IMI treatment. Our data indicate that IMI enhances Zn transfer through the intestinal tract and influences the redistribution of Zn between the blood and brain. These mechanisms might explain the enhanced antidepressant efficacy of combined IMI/Zn treatment observed in the FST in mice. |
format | Online Article Text |
id | pubmed-7551732 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-75517322020-10-14 Imipramine Influences Body Distribution of Supplemental Zinc Which May Enhance Antidepressant Action Rafało-Ulińska, Anna Poleszak, Ewa Szopa, Aleksandra Serefko, Anna Rogowska, Magdalena Sowa, Ireneusz Wójciak, Magdalena Muszyńska, Bożena Krakowska, Agata Gdula-Argasińska, Joanna Kała, Katarzyna Jasiewicz, Barbara Opoka, Włodzimierz Szewczyk, Bernadeta Nowak, Gabriel Nutrients Article Zinc (Zn) was found to enhance the antidepressant efficacy of imipramine (IMI) in human depression and animal tests/models of depression. However, the underlying mechanism for this effect remains unknown. We measured the effect of intragastric (p.o.) combined administration of IMI (60 mg/kg) and Zn (40 mg Zn/kg) in the forced swim test (FST) in mice. The effect of Zn + IMI on serum, brain, and intestinal Zn concentrations; Zn transporter (ZnT, ZIP) protein levels in the intestine and ZnT in the brain; including BDNF (brain-derived neurotrophic factor) and CREB (cAMP response element-binding protein) protein levels in the brain were evaluated. Finally, the effect of IMI on Zn permeability was measured in vitro in colon epithelial Caco-2 cells. The co-administration of IMI and Zn induced antidepressant-like activity in the FST in mice compared to controls and Zn or IMI given alone. This effect correlated with increased BDNF and the ratio of pCREB/CREB protein levels in the prefrontal cortex (PFC) compared to the control group. Zn + IMI co-treatment increased Zn concentrations in the serum and brain compared to the control group. However, in serum, co-administration of IMI and Zn decreased Zn concentration compared to Zn alone treatment. Also, there was a reduction in the Zn-induced enhancement of ZnT1 protein level in the small intestine. Zn + IMI also induced an increase in the ZnT4 protein level in the PFC compared to the control group and normalized the Zn-induced decrease in the ZnT1 protein level in the hippocampus (Hp). The in vitro studies revealed enhanced Zn permeability (observed as the increased transfer of Zn through the intestinal cell membrane) after IMI treatment. Our data indicate that IMI enhances Zn transfer through the intestinal tract and influences the redistribution of Zn between the blood and brain. These mechanisms might explain the enhanced antidepressant efficacy of combined IMI/Zn treatment observed in the FST in mice. MDPI 2020-08-20 /pmc/articles/PMC7551732/ /pubmed/32825449 http://dx.doi.org/10.3390/nu12092529 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Rafało-Ulińska, Anna Poleszak, Ewa Szopa, Aleksandra Serefko, Anna Rogowska, Magdalena Sowa, Ireneusz Wójciak, Magdalena Muszyńska, Bożena Krakowska, Agata Gdula-Argasińska, Joanna Kała, Katarzyna Jasiewicz, Barbara Opoka, Włodzimierz Szewczyk, Bernadeta Nowak, Gabriel Imipramine Influences Body Distribution of Supplemental Zinc Which May Enhance Antidepressant Action |
title | Imipramine Influences Body Distribution of Supplemental Zinc Which May Enhance Antidepressant Action |
title_full | Imipramine Influences Body Distribution of Supplemental Zinc Which May Enhance Antidepressant Action |
title_fullStr | Imipramine Influences Body Distribution of Supplemental Zinc Which May Enhance Antidepressant Action |
title_full_unstemmed | Imipramine Influences Body Distribution of Supplemental Zinc Which May Enhance Antidepressant Action |
title_short | Imipramine Influences Body Distribution of Supplemental Zinc Which May Enhance Antidepressant Action |
title_sort | imipramine influences body distribution of supplemental zinc which may enhance antidepressant action |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7551732/ https://www.ncbi.nlm.nih.gov/pubmed/32825449 http://dx.doi.org/10.3390/nu12092529 |
work_keys_str_mv | AT rafałoulinskaanna imipramineinfluencesbodydistributionofsupplementalzincwhichmayenhanceantidepressantaction AT poleszakewa imipramineinfluencesbodydistributionofsupplementalzincwhichmayenhanceantidepressantaction AT szopaaleksandra imipramineinfluencesbodydistributionofsupplementalzincwhichmayenhanceantidepressantaction AT serefkoanna imipramineinfluencesbodydistributionofsupplementalzincwhichmayenhanceantidepressantaction AT rogowskamagdalena imipramineinfluencesbodydistributionofsupplementalzincwhichmayenhanceantidepressantaction AT sowaireneusz imipramineinfluencesbodydistributionofsupplementalzincwhichmayenhanceantidepressantaction AT wojciakmagdalena imipramineinfluencesbodydistributionofsupplementalzincwhichmayenhanceantidepressantaction AT muszynskabozena imipramineinfluencesbodydistributionofsupplementalzincwhichmayenhanceantidepressantaction AT krakowskaagata imipramineinfluencesbodydistributionofsupplementalzincwhichmayenhanceantidepressantaction AT gdulaargasinskajoanna imipramineinfluencesbodydistributionofsupplementalzincwhichmayenhanceantidepressantaction AT kałakatarzyna imipramineinfluencesbodydistributionofsupplementalzincwhichmayenhanceantidepressantaction AT jasiewiczbarbara imipramineinfluencesbodydistributionofsupplementalzincwhichmayenhanceantidepressantaction AT opokawłodzimierz imipramineinfluencesbodydistributionofsupplementalzincwhichmayenhanceantidepressantaction AT szewczykbernadeta imipramineinfluencesbodydistributionofsupplementalzincwhichmayenhanceantidepressantaction AT nowakgabriel imipramineinfluencesbodydistributionofsupplementalzincwhichmayenhanceantidepressantaction |